MedTrace Logo

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

NCT02759289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 279

Last updated 2020-11-13

No results posted yet for this study

Summary

Investigators will recruit 250 subjects; Group A will consist of 100 prediabetic patients with an A1c of 5.7%-6.4%. Group B will consist of 100 patients with uncontrolled T2D defined as either a) an A1c of 6.5%-7.9% without diabetes medications or b) an A1c ≥ 8.0% with or without diabetes medications. Group C will include 50 participants without T2D or known cardiovascular disease to serve as control comparisons.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jonathan Newman, MPH · New York University Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2020-09-15
Completion
2020-09-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02759289 on ClinicalTrials.gov